Skip to content

Association of response to doxycycline and Azithromycin antibiotics therapy and IL-4 gene ( SR8179190) polymorphism in patients with moderate acne vulgaris

Association of response to doxycycline and Azithromycin antibiotics therapy and IL-4 gene ( SR8179190) polymorphism in patients with moderate acne vulgaris

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230305057631N1
Enrollment
54
Registered
2023-05-24
Start date
2023-03-13
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris. Acne vulgaris

Interventions

Intervention 1: Intervention group: At first, the patients were examined by a dermatologist and the severity of their acne was measured based on the Michelson acne score, and the patients were subject

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: Acne vulgaris with moderate severity according to the classification system (MAS score) Acne vulgaris with moderate severity according to vaishampayan classification system Age over 12 years

Exclusion criteria

Exclusion criteria: Failure to complete the treatment process by the patient Occurrence of unusual complications during treatment The patient's refusal to continue the treatment process

Design outcomes

Primary

MeasureTime frame
Response to treatment. Timepoint: Before starting the treatment, after the end of the treatment. Method of measurement: MAS score.;Satisfaction level. Timepoint: Before starting the treatment, after the end of the treatment. Method of measurement: check list.;Recovery from the doctor's opinion. Timepoint: Before starting the treatment, after the end of the treatment. Method of measurement: Check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamide Mohammadzadeh

Gonabad University of Medical Sciences

Mohammadzadeh.hamideh@yahoo.com+98 51 5723 6832

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026